Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity

The histone methyltransferase ASH1L plays a role in various diseases, including cancer, and has been validated as a therapeutic target; however, no inhibitors of ASH1L have been reported. Here the authors present small molecule inhibitors of ASH1L and demonstrate their on-target activity in leukemia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: David S. Rogawski, Jing Deng, Hao Li, Hongzhi Miao, Dmitry Borkin, Trupta Purohit, Jiho Song, Jennifer Chase, Shuangjiang Li, Juliano Ndoj, Szymon Klossowski, EunGi Kim, Fengbiao Mao, Bo Zhou, James Ropa, Marta Z. Krotoska, Zhuang Jin, Patricia Ernst, Xiaomin Feng, Gang Huang, Kenichi Nishioka, Samantha Kelly, Miao He, Bo Wen, Duxin Sun, Andrew Muntean, Yali Dou, Ivan Maillard, Tomasz Cierpicki, Jolanta Grembecka
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Q
Acceso en línea:https://doaj.org/article/a51c519c90294569ac5da97219844f37
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a51c519c90294569ac5da97219844f37
record_format dspace
spelling oai:doaj.org-article:a51c519c90294569ac5da97219844f372021-12-02T15:43:05ZDiscovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity10.1038/s41467-021-23152-62041-1723https://doaj.org/article/a51c519c90294569ac5da97219844f372021-05-01T00:00:00Zhttps://doi.org/10.1038/s41467-021-23152-6https://doaj.org/toc/2041-1723The histone methyltransferase ASH1L plays a role in various diseases, including cancer, and has been validated as a therapeutic target; however, no inhibitors of ASH1L have been reported. Here the authors present small molecule inhibitors of ASH1L and demonstrate their on-target activity in leukemia cells and a mouse model of leukemia.David S. RogawskiJing DengHao LiHongzhi MiaoDmitry BorkinTrupta PurohitJiho SongJennifer ChaseShuangjiang LiJuliano NdojSzymon KlossowskiEunGi KimFengbiao MaoBo ZhouJames RopaMarta Z. KrotoskaZhuang JinPatricia ErnstXiaomin FengGang HuangKenichi NishiokaSamantha KellyMiao HeBo WenDuxin SunAndrew MunteanYali DouIvan MaillardTomasz CierpickiJolanta GrembeckaNature PortfolioarticleScienceQENNature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
David S. Rogawski
Jing Deng
Hao Li
Hongzhi Miao
Dmitry Borkin
Trupta Purohit
Jiho Song
Jennifer Chase
Shuangjiang Li
Juliano Ndoj
Szymon Klossowski
EunGi Kim
Fengbiao Mao
Bo Zhou
James Ropa
Marta Z. Krotoska
Zhuang Jin
Patricia Ernst
Xiaomin Feng
Gang Huang
Kenichi Nishioka
Samantha Kelly
Miao He
Bo Wen
Duxin Sun
Andrew Muntean
Yali Dou
Ivan Maillard
Tomasz Cierpicki
Jolanta Grembecka
Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
description The histone methyltransferase ASH1L plays a role in various diseases, including cancer, and has been validated as a therapeutic target; however, no inhibitors of ASH1L have been reported. Here the authors present small molecule inhibitors of ASH1L and demonstrate their on-target activity in leukemia cells and a mouse model of leukemia.
format article
author David S. Rogawski
Jing Deng
Hao Li
Hongzhi Miao
Dmitry Borkin
Trupta Purohit
Jiho Song
Jennifer Chase
Shuangjiang Li
Juliano Ndoj
Szymon Klossowski
EunGi Kim
Fengbiao Mao
Bo Zhou
James Ropa
Marta Z. Krotoska
Zhuang Jin
Patricia Ernst
Xiaomin Feng
Gang Huang
Kenichi Nishioka
Samantha Kelly
Miao He
Bo Wen
Duxin Sun
Andrew Muntean
Yali Dou
Ivan Maillard
Tomasz Cierpicki
Jolanta Grembecka
author_facet David S. Rogawski
Jing Deng
Hao Li
Hongzhi Miao
Dmitry Borkin
Trupta Purohit
Jiho Song
Jennifer Chase
Shuangjiang Li
Juliano Ndoj
Szymon Klossowski
EunGi Kim
Fengbiao Mao
Bo Zhou
James Ropa
Marta Z. Krotoska
Zhuang Jin
Patricia Ernst
Xiaomin Feng
Gang Huang
Kenichi Nishioka
Samantha Kelly
Miao He
Bo Wen
Duxin Sun
Andrew Muntean
Yali Dou
Ivan Maillard
Tomasz Cierpicki
Jolanta Grembecka
author_sort David S. Rogawski
title Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
title_short Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
title_full Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
title_fullStr Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
title_full_unstemmed Discovery of first-in-class inhibitors of ASH1L histone methyltransferase with anti-leukemic activity
title_sort discovery of first-in-class inhibitors of ash1l histone methyltransferase with anti-leukemic activity
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/a51c519c90294569ac5da97219844f37
work_keys_str_mv AT davidsrogawski discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT jingdeng discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT haoli discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT hongzhimiao discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT dmitryborkin discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT truptapurohit discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT jihosong discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT jenniferchase discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT shuangjiangli discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT julianondoj discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT szymonklossowski discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT eungikim discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT fengbiaomao discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT bozhou discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT jamesropa discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT martazkrotoska discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT zhuangjin discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT patriciaernst discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT xiaominfeng discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT ganghuang discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT kenichinishioka discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT samanthakelly discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT miaohe discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT bowen discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT duxinsun discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT andrewmuntean discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT yalidou discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT ivanmaillard discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT tomaszcierpicki discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
AT jolantagrembecka discoveryoffirstinclassinhibitorsofash1lhistonemethyltransferasewithantileukemicactivity
_version_ 1718385826424946688